Physician

Magdolna Solti, MD

According to 2025 Medicare claims, Magdolna Solti, MD (NPI: 1629062542) practices hematology in the Portland-Vancouver-Hillsboro, OR-WA market, with the plurality of this provider's patient population coming from Clark, WA. This provider's primary affiliated billing organization is NORTHWEST CANCER SPECIALISTS PC (NPI: 1407828114; TIN: 931280206) and primary practice location at 98684-6930. Solti is affiliated with the PSW ACO (ACO ID: A5323), participating under the MSSP model.

Solti's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 720 traditional Medicare patients, billed 98,593 HCPCS/CPT codes, and received $1,424,142 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,505 prescription claims across 344 beneficiaries totaling $5,926,188 in drug costs, led by Ibrance (Palbociclib). DME data shows 11 claims. Open Payments data shows 2 records totaling $203. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $776,852 to $1,424,142. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $908,112 to $5,926,188. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$756K$1.5M2015 Medicare payment: $776,852 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $848,570 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $826,963 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,191,302 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,313,110 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,381,207 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,512,758 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,419,078 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,210,200 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,424,142 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201569169,951$776,852
201676765,638$848,570
201781066,301$826,963
201886185,635$1,191,302
201983281,634$1,313,110
202069890,852$1,381,207
202182199,028$1,512,758
20221,044112,929$1,419,078
202378979,193$1,210,200
202472098,593$1,424,142

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$3.0M$5.9M2015 Drug cost: $908,112 (USD; Tot_Drug_Cst)2016 Drug cost: $982,884 (USD; Tot_Drug_Cst)2017 Drug cost: $1,219,858 (USD; Tot_Drug_Cst)2018 Drug cost: $2,171,342 (USD; Tot_Drug_Cst)2019 Drug cost: $3,393,154 (USD; Tot_Drug_Cst)2020 Drug cost: $2,774,437 (USD; Tot_Drug_Cst)2021 Drug cost: $3,385,755 (USD; Tot_Drug_Cst)2022 Drug cost: $3,692,082 (USD; Tot_Drug_Cst)2023 Drug cost: $4,323,357 (USD; Tot_Drug_Cst)2024 Drug cost: $5,926,188 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152471,698$908,112
20162461,577$982,884
20172541,650$1,219,858
20182901,906$2,171,342
20193142,015$3,393,154
20202922,032$2,774,437
20213191,945$3,385,755
20223292,012$3,692,082
20233352,211$4,323,357
20243442,505$5,926,188

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$9.1K$18K2015 Medicare payment: $18,264 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $1,268 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $2,566 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $5,318 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $138 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R38$18,264
20161115$1,268
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/R47$2,566
2021N/R89$5,318
2022N/RN/RN/R
2023N/RN/RN/R
2024N/R11$138

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more156271$91
83883Nephelometry, test method using light125516$13
80053Blood test, comprehensive group of blood chemicals224672$10
36415Insertion of needle into vein for collection of blood sample219631$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count224761$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
IbrancePalbociclib822,234$1,166,923
LenalidomideLenalidomide691,952$797,841
VerzenioAbemaciclib481,344$706,960
JakafiRuxolitinib Phosphate33990$549,671
OrserduElacestrant Hcl19570$438,200

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R11$138

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$203Stemline Therapeutics Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Magdolna Solti, MD?

Tedicare shows public-source Medicare data for Magdolna Solti, MD (NPI 1629062542), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Magdolna Solti, MD have ACO affiliation data?

Magdolna Solti, MD is shown with ACO affiliation data for PSW ACO (MSSP, ACO ID A5323).

What billing organization is linked to Magdolna Solti, MD?

Magdolna Solti, MD is linked to NORTHWEST CANCER SPECIALISTS PC (billing NPI 1407828114) in the available physician profile data.

Does Magdolna Solti, MD have Open Payments data?

Magdolna Solti, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.